Stay updated on IRX-2 Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.

Latest updates to the IRX-2 Combo in Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.4.3 deployed; appears to be a minor update with no changes to study content or eligibility criteria.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and the prior v3.4.1 revision banner.SummaryDifference0.4%

- Check73 days agoChange DetectedThe page now includes notices about government funding and NIH operating status updates, and the site version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded a Show glossary option and updated multiple UI labels to reflect the new revision (v3.4.0) and capitalization changes, including Last Update and No FEAR Act Data lines.SummaryDifference0.2%

Stay in the know with updates to IRX-2 Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.